Drug intelligence / Profile preview

CHAMSC-201

Development stage: Unknown
Lead developer: CHA Biotech
Modality: Stem Cell Therapies → Cell Therapies

Overview

CHAMSC-201 is a regenerative **allogeneic Wharton's jelly mesenchymal stem cell therapy** being developed by CHA for reproductive indications including premature ovarian insufficiency, endometrial disorders, and support of genetic stability of IVF oocytes. The product is derived from umbilical cord Wharton's jelly and is intended to act through the well-established mesenchymal stem cell biology of **paracrine trophic signaling, immunomodulation, anti-inflammatory effects, and tissue-repair support**, rather than a single defined molecular target. Based on CHA's pipeline materials, CHAMSC-201 is positioned as an off-the-shelf cell therapy program in **Phase 1/2** development, with U.S. IND activity noted for the global allogeneic platform.

Other names: Cord Wharton's jelly MSC therapyallogeneic Wharton's jelly MSC therapy

Beyond the preview

Go deeper on CHAMSC-201.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CHAMSC-201.

Explore the full profile